Comparing Octagam vs Panzyga
| Octagam (immune globulin intravenous) | Panzyga (immune globulin intravenous) |
|
|---|
| Octagam (immune globulin intravenous) | Panzyga (immune globulin intravenous) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Dermatomyositis, Primary Immunodeficiency Syndrome, Immune Thrombocytopenia. Octagam may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Primary Immunodeficiency Syndrome, Immune Thrombocytopenia. Panzyga may also be used for purposes not listed in this medication guide. View more |
Related suggestions Primary Immunodeficiency Syndrome
Immune Thrombocytopenia
|
|||||||||||||||
| More about Octagam (immune globulin intravenous) | More about Panzyga (immune globulin intravenous) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Octagam has an average rating of 8.3 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Panzyga has an average rating of 6.8 out of 10 from a total of 4 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Octagam side effects |
View all Panzyga side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Octagam prices |
View all Panzyga prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other immune globulin intravenous brands include: Alyglo, Asceniv, Bivigam, Carimune NF, Flebogamma, Gammagard S/D, Gammaplex, Panzyga, Privigen, Yimmugo View more | Other immune globulin intravenous brands include: Alyglo, Asceniv, Bivigam, Carimune NF, Flebogamma, Gammagard S/D, Gammaplex, Octagam, Privigen, Yimmugo View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
576 hours |
576 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 107 drugs are known to interact with Octagam:
|
A total of 107 drugs are known to interact with Panzyga:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.